恆指跌逾250點曾考驗23,500創逾一年低 港交所/美團/潤地/百威亞太續跌3%-4%
美國10月NAR成屋銷售指數按月轉升7.5%遠勝預期,加上美國總統拜登表明現階段無意封城應對Omicron新變種病毒,美股昨晚在藍籌科技與大型科網股有趁低吸納,以及費城半導體指數急彈4.1%帶動,三大指數反彈0.7%-1.9%,納指及標普彈力最強,道指由曾回升388點,收窄至僅反彈236點或0.7%收35,135。美股期貨續升近0.1%-0.3%,道指期貨追升高見35,234,現報報35,175,續升98點或0.3%。
11月中國官方製造業PMI意外重現擴張,由前值49.2,升至50.1,高於市場預期49.7;期內非製造業PMI僅微降至52.3,高於市場預期51.5。亞太區股市今天普遍隨美股反彈,尤其是台股及澳紐股市回升0.9%-1.5%,日經由曾回升逾430點或1.5%至28,718,半日收28,498,僅回升214點或不足0.8%,但港韓菲股逆市跌逾1%。
恆指三連跌,承過去兩連天累挫逾880點勢,今早在騰訊(00700.HK)/美團(03690.HK)/龍湖(00960.HK)/潤地(01109.HK)主導低開69點或0.3%報23,782,最高見23,888已行人止步,掉頭失守上月初所創一年低位23,681,最低見23,503,創逾13個月低,現報23,593,續跌258點或1.1%,成交額703億元。
藍籌股普遍受壓,季度虧損超預期遭多間大行削價的美團承昨天急挫7%勢,今早低見232.4元,現報235.8元,續跌3.8%。騰訊低見451元,現報456元,續跌1.4%
創科(00669.HK)、萬洲(00288.HK)、吉利(00175.HK)及百威亞太(01876.HK)跌2%-3.8%,後兩者沽壓最大,分別報23.15元及19.44元(失守50天線)。
潤地四連跌,股價曾失守牛熊線(32.9元),低見32.65元,現報33元,續跌3.8%;龍湖五連跌兼失守20天線,最低見37.3元,現報37.65元,續跌2.5%。恆地(00012.HK)回吐2.1%報32.35元。
金融股以港交所(00388.HK)表現最差,股價三連跌,最低見430.2元,創逾八個月低,現報431.8元,續挫3%。匯控(00005.HK)、友邦(01299.HK)及兩大大藍籌內險股跌0.9%-1.3%,前者沽壓最大報43.2元。
信義光能(00968.HK)由逾五個月低位兩連彈,報14.06元,續升3%。藥明生物(02269.HK)續彈1.5%報108元;瑞聲(02018.HK)回升1.6%報34.7元。碧桂園服務(06098.HK)升2%報48.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.